Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that its Trevo System for acute ischemic stroke has received regulatory approval in both Europe (CE Mark) and Canada.

Leading EU centers began initial clinical evaluation of the Trevo System following receipt of CE Mark in late 2009.  Numerous cases have been performed and early clinical feedback continues to be positive.

Maria Sainz, President and CEO of Concentric Medical, said, "I am thrilled Concentric has received these approvals and that physician feedback on our initial cases has been so encouraging.  These approvals combined with the positive feedback will allow us to introduce the Trevo System to customers in Europe and Canada in the near future."